Source:http://linkedlifedata.com/resource/pubmed/id/11380461
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-5-30
|
pubmed:abstractText |
Persistent B-cell lymphocytosis (PPBL) is a haematological disorder diagnosed primarily in adult female smokers that is characterized by a polyclonal increase in peripheral blood B lymphocytes and a moderate elevation of serum IgM. B lymphocyte-associated cellular abnormalities, such as the occurrence of multi-lobed nuclei, increased bcl2/Ig gene rearrangements and the identification of an extra long-arm chromosome (i3)(q10) in the B-cell population, indicate that PPBL could be part of a multi-step process leading to the emergence of a malignant B lymphoproliferation. However, the resulting impact on cellular functional properties remains to be elucidated. Our goal was to address that aspect via the study of B-cell activity following stimulation through CD40, a key molecule of the tumour necrosis factor receptor superfamily involved in B lymphocyte development. In contrast to normal B cells, PPBL B lymphocytes were unable to respond to the proliferative signal delivered in vitro by CD40, indicating a defect in the CD40 activation pathway. Polymerase chain reaction amplification and sequencing of the receptor as well as FACScan analysis of patient B lymphocytes dismissed the possibility of a defect in either CD40 structure or expression. Moreover, Western blot analysis of tyrosine phosphorylation, an early event in the CD40-signalling cascade, was similar in patients and controls, leading to the conclusion that the defect affecting B lymphocytes in PPBL patients is probably located downstream of that signalling cascade.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
699-705
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11380461-Adult,
pubmed-meshheading:11380461-Antigens, CD40,
pubmed-meshheading:11380461-B-Lymphocytes,
pubmed-meshheading:11380461-Blotting, Western,
pubmed-meshheading:11380461-Cell Division,
pubmed-meshheading:11380461-Cells, Cultured,
pubmed-meshheading:11380461-Female,
pubmed-meshheading:11380461-Flow Cytometry,
pubmed-meshheading:11380461-Humans,
pubmed-meshheading:11380461-Lymphocytosis,
pubmed-meshheading:11380461-Middle Aged,
pubmed-meshheading:11380461-Phosphorylation,
pubmed-meshheading:11380461-Polymerase Chain Reaction,
pubmed-meshheading:11380461-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:11380461-Signal Transduction
|
pubmed:year |
2001
|
pubmed:articleTitle |
Lack of CD40-dependent B-cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B-cell lymphocytosis.
|
pubmed:affiliation |
CREFSIP, Départment de Biochimie and Microbiologie, Université Laval, and Centre d'hématologie et d'immunologie clinique, CHA, Québec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|